Biodesix Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Biodesix, Inc. (BDSX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-42.93-52.15-65.45-43.16-31.35
Depreciation & Amortization5.465.515.843.188.71
Stock Based Compensation6.645.375.964.943.71
Change in Working Capital-21.67-7.02-6.824.59-4.80
Change in Accounts Receivable-1.81-4.72-1.5011.45-10.31
Change in Inventory0.020.000.000.000.00
Change in Accounts Payable1.640.51-0.77-7.4311.65
Change in Other Working Capital-21.5223.608.412.24-8.40
Other Operating Activities3.8623.608.412.035.31
Net Cash from Operating Activities-48.65-22.87-44.97-28.22-21.37
Investing Activities
Capital Expenditures-3.23-23.06-3.53-2.241.95
Acquisitions0.000.000.001.620.82
Sales/Maturities of Investments0.00-0.14-0.24-0.31-0.98
Other Investing Activities-0.21-0.14-0.24-0.31-0.98
Net Cash from Investing Activities-3.44-23.06-3.53-2.55-2.93
Financing Activities
Debt Repayment-0.05-0.05-28.60-45.430.00
Common Stock Issued55.6328.1359.5417.4472.00
Other Financing Activities-3.52-9.68-17.78-0.833.08
Net Cash from Financing Activities52.0529.1358.881.2681.13
Summary
Net Change in Cash-0.04-16.8010.38-29.5156.84
Cash at Beginning of Period26.3743.1732.8062.315.47
Cash at End of Period26.3326.3743.1732.8062.31
Free Cash Flow-51.88-45.93-48.51-30.46-23.31
Supplemental Disclosures
Interest Paid7.023.991.011.681.84